Clinical Trial Update: A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression. [Phase 4]

View source ↗

Summary

A Phase 4 placebo-controlled trial of ropinirole for refractory bipolar depression is being conducted at Sheba Medical Center; the trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder

Drugs mentioned

• Ropinirole (ropinirole)

Snippet

Sponsor: Sheba Medical Center | Conditions: Bipolar Disorder, Major Depressive Disorder | Phase 4 | Status: UNKNOWN